Literature DB >> 15985746

Transfusion associated GVHD.

Inderpreet Sohi1, Sunitha Jacob.   

Abstract

Transfusion-associated graft-versus-host disease (TA-GVHD) is an under-diagnosed condition in clinical practice. It can occur in immunocompromised as well as immunocompetent hosts and may follow allogeneic bone marrow transplant or transfusion from a related donor. The clinical course is stormy with a high mortality rate. Avoiding the use of blood transfusions from related donors and irradiation of blood products can prevent graft versus host disease. A case of graft versus host disease following related donor transfusion is presented here.

Entities:  

Mesh:

Year:  2005        PMID: 15985746     DOI: 10.1007/BF02724436

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

1.  Post-transfusion graft versus host disease - an under recognized entity.

Authors:  B Jindal; A Narang; R Das
Journal:  Indian Pediatr       Date:  2001-02       Impact factor: 1.411

Review 2.  Transfusion-associated graft-versus-host disease.

Authors:  Marlis L Schroeder
Journal:  Br J Haematol       Date:  2002-05       Impact factor: 6.998

Review 3.  Biopsy interpretation in bone marrow transplantation.

Authors:  D C Snover
Journal:  Pathol Annu       Date:  1989

Review 4.  Transfusion-associated graft-versus-host disease: current concepts and future trends.

Authors:  M J Seghatchian; F Ala
Journal:  Transfus Sci       Date:  1995-06

Review 5.  Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.

Authors:  L D Petz; L Calhoun; P Yam; M Cecka; G Schiller; A R Faitlowicz; R Herron; D Sayah; R B Wallace; A Belldegrun
Journal:  Transfusion       Date:  1993-09       Impact factor: 3.157

Review 6.  What's new in transfusion medicine?

Authors:  C S Manno
Journal:  Pediatr Clin North Am       Date:  1996-06       Impact factor: 3.278

Review 7.  Prevention of transfusion-associated graft-vs-host disease.

Authors:  P V Holland
Journal:  Arch Pathol Lab Med       Date:  1989-03       Impact factor: 5.534

8.  Transfusion-associated graft versus host disease.

Authors:  Chris Parshuram; John Doyle; Wendy Lau; Sam D Shemie
Journal:  Pediatr Crit Care Med       Date:  2002-01       Impact factor: 3.624

Review 9.  Posttransfusion graft-versus-host disease in Japanese newborns.

Authors:  H Ohto; K C Anderson
Journal:  Transfusion       Date:  1996-02       Impact factor: 3.157

10.  Spontaneous resolution of transfusion-associated graft-versus-host disease.

Authors:  S Mori; H Matsushita; K Ozaki; A Ishida; M Tokuhira; H Nakajima; M Kizaki; H Sugiura; A Kikuchi; M Handa
Journal:  Transfusion       Date:  1995-05       Impact factor: 3.157

  10 in total
  1 in total

1.  Recommendations on Selection and Processing of RBC Components for Pediatric Patients From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Nicole D Zantek; Robert I Parker; Leo M van de Watering; Cassandra D Josephson; Scot T Bateman; Stacey L Valentine; Meghan Delaney
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.